Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016

IMPORTANCE: Clinical trial evidence used to support drug approval is typically the only information on benefits and harms that patients and clinicians can use for decision-making when novel cancer therapies become available. Various evaluations have raised concern about the uncertainty surrounding t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladanie, Aviv, Schmitt, Andreas M., Speich, Benjamin, Naudet, Florian, Agarwal, Arnav, Pereira, Tiago V., Sclafani, Francesco, Herbrand, Amanda K., Briel, Matthias, Martin-Liberal, Juan, Schmid, Thomas, Ewald, Hannah, Ioannidis, John P. A., Bucher, Heiner C., Kasenda, Benjamin, Hemkens, Lars G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656288/
https://www.ncbi.nlm.nih.gov/pubmed/33170262
http://dx.doi.org/10.1001/jamanetworkopen.2020.24406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656288/
https://www.ncbi.nlm.nih.gov/pubmed/33170262
http://dx.doi.org/10.1001/jamanetworkopen.2020.24406

Ejemplares similares